Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)
NCT02262637 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4814
Last updated 2014-10-13
Summary
Study to evaluate efficacy and tolerability of Micardis®/MicardisPlus® under usual daily-practice prescribing-conditions with emphasis on effects on endorgan damage in the clientele of cardiologists, nephrologists, and diabetologists
Conditions
Interventions
- DRUG
-
Micardis®
- DRUG
-
MicardisPlus®
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-09-30
- Primary Completion
- 2006-03-31
More Related Trials
-
Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients
NCT00879411 ·Status: COMPLETED
-
Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension
NCT02238275 ·Status: COMPLETED
-
Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension
NCT00257491 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients
NCT01108809 ·Status: COMPLETED
-
Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects
NCT02262572 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure
NCT02242864 ·Status: COMPLETED
-
Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan
NCT01108796 ·Status: COMPLETED
-
Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension
NCT02242838 ·Status: COMPLETED
-
Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)
NCT02262611 ·Status: COMPLETED
-
Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension
NCT02177409 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)
NCT02242396 ·Status: COMPLETED
-
Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension
NCT02177422 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise
NCT00946829 ·Status: COMPLETED
-
Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients
NCT00863980 ·Status: TERMINATED ·Phase: NA
-
Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM
NCT00274612 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus
NCT02242825 ·Status: COMPLETED
-
Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension
NCT00659607 ·Status: COMPLETED
-
Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
NCT00281580 ·Status: COMPLETED ·Phase: PHASE3
-
PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)
NCT00274638 ·Status: COMPLETED ·Phase: PHASE4
-
Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)
NCT02243566 ·Status: COMPLETED
-
Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial
NCT00147264 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice
NCT00982735 ·Status: COMPLETED
-
A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)
NCT02200653 ·Status: COMPLETED ·Phase: PHASE4
-
Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients
NCT02172586 ·Status: COMPLETED ·Phase: PHASE4
-
PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
NCT00274599 ·Status: COMPLETED ·Phase: PHASE4